Habibi, M. A., Rashidi, F., Gharedaghi, H., Arshadi, M. R., & Kazemivand, S. (2024). The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma. European Journal of Clinical Pharmacology, 80(9), 1259. https://doi.org/10.1007/s00228-024-03695-5
Chicago Style (17th ed.) CitationHabibi, Mohammad Amin, Farhang Rashidi, Hossein Gharedaghi, Mohammad Reza Arshadi, and Sana Kazemivand. "The Safety and Efficacy of Bevacizumab in Treatment of Recurrent Low-grade Glioma." European Journal of Clinical Pharmacology 80, no. 9 (2024): 1259. https://doi.org/10.1007/s00228-024-03695-5.
MLA (9th ed.) CitationHabibi, Mohammad Amin, et al. "The Safety and Efficacy of Bevacizumab in Treatment of Recurrent Low-grade Glioma." European Journal of Clinical Pharmacology, vol. 80, no. 9, 2024, p. 1259, https://doi.org/10.1007/s00228-024-03695-5.
